Full Member
Vanessa Adaui Sicheri
Membership since:
2025
Field of activity:
Other Memberships/Affiliations
National Academy of Science and Technology (ANCYT). Lima, Perú
Degrees:
2011
Doctorate Medical and Health Sciences incl Neurosciences
Publications resulting from Research
1. Yardley V, Ortuño N, Llanos-Cuentas A, Chappuis F, De Doncker S, Ramirez L, Croft S, Arevalo J, Adaui V, Bermudez H, Decuypere S, Dujardin JC. (2006) American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility? J Infect Dis. 194(8): 1168-1175.
2. Best I, Adaui V, Verdonck K, González E, Tipismana M, Clark D, Gotuzzo E, Vanham G. (2006) Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru. Clin Exp Immunol. 146(2): 226-233.
3. Adaui V, Verdonck K, Best I, González E, Tipismana M, Arévalo J, Vanham G, Campos M, Zimic M, Gotuzzo E. (2006) SYBR green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: Influence of clinical status, sex and familial relatedness. J Neurovirol. 12(6): 456-465.
4. Rozas M, De Doncker S, Adaui V, Coronado X, Barnabé C, Tibayrenc M, Solari A, Dujardin JC. (2007) Multilocus polymerase chain reaction restriction fragment-length polymorphism genotyping of Trypanosoma cruzi (Chagas disease): taxonomic and clinical applications. J Infect Dis. 195(9):1381-1388.
5. Arevalo J, Ramirez L, Adaui V, Zimic M, Tulliano G, Miranda-Verastegui C, Lazo M, Loayza-Muro R, De Doncker S, Maurer A, Chappuis F, Dujardin JC, Llanos-Cuentas A. (2007) Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J Infect Dis. 195(12):1846-1851.
6. Boggild AK, Miranda-Verastegui C, Espinosa D, Arevalo J, Adaui V, Tulliano G, Llanos-Cuentas A, Low DE. (2007) Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru. J Clin Microbiol. 45(11):3680-3684.
7. Gamboa D, Van Eys G, Victoir K, Torres K, Adaui V, Arevalo J, Dujardin JC. (2007) Putative markers of infective life stages in Leishmania (Viannia) braziliensis. Parasitology 134(Pt 12):1689-1698.
8. Moens B, López G, Adaui V, González E, Kerremans L, Clark D, Verdonck K, Gotuzzo E, Vanham G, Cassar O, Gessain A, Vandamme AM, Van Dooren S. (2009) Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination. J Clin Microbiol. 47(11):3682-3691.
9. Talledo M, López G, Huyghe JR, Verdonck K, Adaui V, González E, Best I, Clark D, Vanham G, Gotuzzo E, Van Camp G, Van Laer L. (2010) Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients. J Med Virol. 82(3):460-466.
10. Torres DC, Adaui V, Ribeiro-Alves M, Romero GAS, Arévalo J, Cupolillo E, Dujardin JC. (2010) Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes. Infect Genet Evol. 10(6):727-733.
11. Vanaerschot M, Maes I, Ouakad M, Adaui V, Maes L, De Doncker S, Rijal S, Chappuis F, Dujardin JC, Decuypere S. (2010) Linking in vitro and in vivo survival of clinical Leishmania donovani strains. PLoS One. 5(8). pii: e12211.
12. Adaui V, Schnorbusch K, Zimic M, Gutiérrez A, Decuypere S, Vanaerschot M, De Doncker S, Maes I, Llanos-Cuentas A, Chappuis F, Arévalo J, Dujardin JC. (2011) Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony. Parasitology 138(2):183-193.
13. Adaui V, Castillo D, Zimic M, Gutiérrez A, Decuypere S, Vanaerschot M, De Doncker S, Schnorbusch K, Maes I, Van der Auwera G, Maes L, Llanos-Cuentas A, Arévalo J, Dujardin JC. (2011) Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates. PLoS Negl Trop Dis. 5(5): e1021. doi:10.1371/journal.pntd.0001021.
14. Adaui V, Maes I, Huyse T, Van den Broeck F, Talledo M, Kuhls K, De Doncker S, Maes L, Llanos-Cuentas A, Schönian G, Arevalo J, Dujardin JC. (2011) Multilocus genotyping reveals a polyphyletic pattern among naturally antimony-resistant Leishmania braziliensis isolates from Peru. Infect Genet Evol. 11(8):1873-1880. doi: 10.1016/j.meegid.2011.08.008.
15. Valencia BM, Veland N, Alba M, Adaui V, Arevalo J, Low DE, Llanos-Cuentas A, Boggild AK. (2012) Non-invasive cytology brush PCR for the diagnosis and causative species identification of American cutaneous leishmaniasis in Peru. PLoS One. 7(11):e49738. doi: 10.1371/journal.pone.0049738.
16. Veland N, Valencia BM, Alba M, Adaui V, Llanos-Cuentas A, Arevalo J, Boggild AK. (2013) Simultaneous infection with Leishmania (Viannia) braziliensis and L. (V.) lainsoni in a Peruvian patient with cutaneous leishmaniasis. Am J Trop Med Hyg. 88(4):774-777. doi: 10.4269/ajtmh.12-0594.
17. Jara M, Adaui V, Valencia BM, Martinez D, Alba M, Castrillon C, Cruz M, Cruz I, Van der Auwera G, Llanos-Cuentas A, Dujardin JC, Arevalo J. (2013) Real-time PCR assay for detection and quantification of Leishmania (Viannia) organisms in skin and mucosal lesions: exploratory study of parasite load and clinical parameters. J Clin Microbiol. 51(6): 1826-1833. doi:10.1128/JCM.00208-13.
18. Cruz I, Millet A, Carrillo E, Chenik M, Salotra P, Verma S, Veland N, Jara M, Adaui V, Castrillón C, Arévalo J, Moreno J, Cañavate C. (2013) An approach for interlaboratory comparison of conventional and real-time PCR assays for diagnosis of human leishmaniasis. Exp Parasitol. 134(3): 281-289. doi: 10.1016/j.exppara.2013.03.026.
19. Nühs A, Schäfer C, Zander D, Trübe L, Tejera Nevado P, Schmidt S, Arevalo J, Adaui V, Maes L, Dujardin J-C, Clos J. (2014) A novel marker, ARM58, confers antimony resistance to Leishmania spp. Int. J. Parasitol: Drugs and Drug Resist. 4:37–47. http://dx.doi.org/10.1016/j.ijpddr.2013.11.004.
20. Suárez M, Valencia BM, Jara M, Alba M, Boggild AK, Dujardin JC, Llanos-Cuentas A, Arevalo J, Adaui V. (2015) Quantification of Leishmania (Viannia) kinetoplast DNA in ulcers of cutaneous leishmaniasis reveals inter-site and inter-sampling variability in parasite load. PLoS Negl Trop Dis. 9(7):e0003936. doi: 10.1371/journal.pntd.0003936.
21. Adaui V, Lye LF, Akopyants NS, Zimic M, Llanos-Cuentas A, Garcia L, Maes I, De Doncker S, Dobson DE, Arevalo J, Dujardin JC, Beverley SM. (2016) Association of the endobiont double-stranded RNA virus LRV1 with treatment failure for human leishmaniasis caused by Leishmania braziliensis in Peru and Bolivia. J Infect Dis. 213(1):112-21. doi: 10.1093/infdis/jiv354. Epub 2015 Jun 29.
22. Jara M, Valencia BM, Adaui V, Alba M, Lau R, Arevalo J, Llanos-Cuentas A, Boggild AK. (2016) Quantitative kinetoplast DNA assessment during treatment of mucosal leishmaniasis as a potential biomarker of outcome: a pilot study. Am J Trop Med Hyg. 94(1):107-13. doi: 10.4269/ajtmh.15-0514. Epub 2015 Oct 19.
23. Martínez DY, Verdonck K, Kaye PM, Adaui V, Polman K, Llanos-Cuentas A, Dujardin JC, Boelaert M. (2018) Tegumentary leishmaniasis and coinfections other than HIV. PLoS Negl Trop Dis. 12(3):e0006125. doi: 10.1371/journal.pntd.0006125. eCollection 2018 Mar. Review.
2. Best I, Adaui V, Verdonck K, González E, Tipismana M, Clark D, Gotuzzo E, Vanham G. (2006) Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru. Clin Exp Immunol. 146(2): 226-233.
3. Adaui V, Verdonck K, Best I, González E, Tipismana M, Arévalo J, Vanham G, Campos M, Zimic M, Gotuzzo E. (2006) SYBR green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: Influence of clinical status, sex and familial relatedness. J Neurovirol. 12(6): 456-465.
4. Rozas M, De Doncker S, Adaui V, Coronado X, Barnabé C, Tibayrenc M, Solari A, Dujardin JC. (2007) Multilocus polymerase chain reaction restriction fragment-length polymorphism genotyping of Trypanosoma cruzi (Chagas disease): taxonomic and clinical applications. J Infect Dis. 195(9):1381-1388.
5. Arevalo J, Ramirez L, Adaui V, Zimic M, Tulliano G, Miranda-Verastegui C, Lazo M, Loayza-Muro R, De Doncker S, Maurer A, Chappuis F, Dujardin JC, Llanos-Cuentas A. (2007) Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J Infect Dis. 195(12):1846-1851.
6. Boggild AK, Miranda-Verastegui C, Espinosa D, Arevalo J, Adaui V, Tulliano G, Llanos-Cuentas A, Low DE. (2007) Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru. J Clin Microbiol. 45(11):3680-3684.
7. Gamboa D, Van Eys G, Victoir K, Torres K, Adaui V, Arevalo J, Dujardin JC. (2007) Putative markers of infective life stages in Leishmania (Viannia) braziliensis. Parasitology 134(Pt 12):1689-1698.
8. Moens B, López G, Adaui V, González E, Kerremans L, Clark D, Verdonck K, Gotuzzo E, Vanham G, Cassar O, Gessain A, Vandamme AM, Van Dooren S. (2009) Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination. J Clin Microbiol. 47(11):3682-3691.
9. Talledo M, López G, Huyghe JR, Verdonck K, Adaui V, González E, Best I, Clark D, Vanham G, Gotuzzo E, Van Camp G, Van Laer L. (2010) Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients. J Med Virol. 82(3):460-466.
10. Torres DC, Adaui V, Ribeiro-Alves M, Romero GAS, Arévalo J, Cupolillo E, Dujardin JC. (2010) Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes. Infect Genet Evol. 10(6):727-733.
11. Vanaerschot M, Maes I, Ouakad M, Adaui V, Maes L, De Doncker S, Rijal S, Chappuis F, Dujardin JC, Decuypere S. (2010) Linking in vitro and in vivo survival of clinical Leishmania donovani strains. PLoS One. 5(8). pii: e12211.
12. Adaui V, Schnorbusch K, Zimic M, Gutiérrez A, Decuypere S, Vanaerschot M, De Doncker S, Maes I, Llanos-Cuentas A, Chappuis F, Arévalo J, Dujardin JC. (2011) Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony. Parasitology 138(2):183-193.
13. Adaui V, Castillo D, Zimic M, Gutiérrez A, Decuypere S, Vanaerschot M, De Doncker S, Schnorbusch K, Maes I, Van der Auwera G, Maes L, Llanos-Cuentas A, Arévalo J, Dujardin JC. (2011) Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates. PLoS Negl Trop Dis. 5(5): e1021. doi:10.1371/journal.pntd.0001021.
14. Adaui V, Maes I, Huyse T, Van den Broeck F, Talledo M, Kuhls K, De Doncker S, Maes L, Llanos-Cuentas A, Schönian G, Arevalo J, Dujardin JC. (2011) Multilocus genotyping reveals a polyphyletic pattern among naturally antimony-resistant Leishmania braziliensis isolates from Peru. Infect Genet Evol. 11(8):1873-1880. doi: 10.1016/j.meegid.2011.08.008.
15. Valencia BM, Veland N, Alba M, Adaui V, Arevalo J, Low DE, Llanos-Cuentas A, Boggild AK. (2012) Non-invasive cytology brush PCR for the diagnosis and causative species identification of American cutaneous leishmaniasis in Peru. PLoS One. 7(11):e49738. doi: 10.1371/journal.pone.0049738.
16. Veland N, Valencia BM, Alba M, Adaui V, Llanos-Cuentas A, Arevalo J, Boggild AK. (2013) Simultaneous infection with Leishmania (Viannia) braziliensis and L. (V.) lainsoni in a Peruvian patient with cutaneous leishmaniasis. Am J Trop Med Hyg. 88(4):774-777. doi: 10.4269/ajtmh.12-0594.
17. Jara M, Adaui V, Valencia BM, Martinez D, Alba M, Castrillon C, Cruz M, Cruz I, Van der Auwera G, Llanos-Cuentas A, Dujardin JC, Arevalo J. (2013) Real-time PCR assay for detection and quantification of Leishmania (Viannia) organisms in skin and mucosal lesions: exploratory study of parasite load and clinical parameters. J Clin Microbiol. 51(6): 1826-1833. doi:10.1128/JCM.00208-13.
18. Cruz I, Millet A, Carrillo E, Chenik M, Salotra P, Verma S, Veland N, Jara M, Adaui V, Castrillón C, Arévalo J, Moreno J, Cañavate C. (2013) An approach for interlaboratory comparison of conventional and real-time PCR assays for diagnosis of human leishmaniasis. Exp Parasitol. 134(3): 281-289. doi: 10.1016/j.exppara.2013.03.026.
19. Nühs A, Schäfer C, Zander D, Trübe L, Tejera Nevado P, Schmidt S, Arevalo J, Adaui V, Maes L, Dujardin J-C, Clos J. (2014) A novel marker, ARM58, confers antimony resistance to Leishmania spp. Int. J. Parasitol: Drugs and Drug Resist. 4:37–47. http://dx.doi.org/10.1016/j.ijpddr.2013.11.004.
20. Suárez M, Valencia BM, Jara M, Alba M, Boggild AK, Dujardin JC, Llanos-Cuentas A, Arevalo J, Adaui V. (2015) Quantification of Leishmania (Viannia) kinetoplast DNA in ulcers of cutaneous leishmaniasis reveals inter-site and inter-sampling variability in parasite load. PLoS Negl Trop Dis. 9(7):e0003936. doi: 10.1371/journal.pntd.0003936.
21. Adaui V, Lye LF, Akopyants NS, Zimic M, Llanos-Cuentas A, Garcia L, Maes I, De Doncker S, Dobson DE, Arevalo J, Dujardin JC, Beverley SM. (2016) Association of the endobiont double-stranded RNA virus LRV1 with treatment failure for human leishmaniasis caused by Leishmania braziliensis in Peru and Bolivia. J Infect Dis. 213(1):112-21. doi: 10.1093/infdis/jiv354. Epub 2015 Jun 29.
22. Jara M, Valencia BM, Adaui V, Alba M, Lau R, Arevalo J, Llanos-Cuentas A, Boggild AK. (2016) Quantitative kinetoplast DNA assessment during treatment of mucosal leishmaniasis as a potential biomarker of outcome: a pilot study. Am J Trop Med Hyg. 94(1):107-13. doi: 10.4269/ajtmh.15-0514. Epub 2015 Oct 19.
23. Martínez DY, Verdonck K, Kaye PM, Adaui V, Polman K, Llanos-Cuentas A, Dujardin JC, Boelaert M. (2018) Tegumentary leishmaniasis and coinfections other than HIV. PLoS Negl Trop Dis. 12(3):e0006125. doi: 10.1371/journal.pntd.0006125. eCollection 2018 Mar. Review.
28th Annual Meeting of the German Society for Parasitology (DGP)
2025
Berlin, GermanyFirst National Workshop of Scientific Women “Generation of Knowledge in Science and Technology”. Organized by the National Academy of Sciences and IANAS (The Inter-American Network of Academies of Sciences).
2025
Lima, Perú‘International workshop on the standardization of a real time PCR assay for the quantification of parasite load for cutaneous leishmaniasis management in the Americas’.
2025
PECET, Universidad de Antioquia, Medellín-Colombia6th World Congress on Leishmaniasis (WorldLeish-6)
2025
Toledo, SpainAnnual Meeting of the Alexander von Humboldt Foundation
2025
Berlin, Germany28th Annual Meeting of the German Society for Parasitology
2025
Berlin, Germany